| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a chronic respiratory disease state strategic plan |
|
|
developed by the Department of State Health Services. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. (a) The Department of State Health Services |
|
|
shall develop a strategic plan to significantly reduce morbidity |
|
|
and mortality from chronic respiratory disease, including asthma |
|
|
and chronic obstructive pulmonary disease. |
|
|
(b) In developing the strategic plan, the Department of |
|
|
State Health Services shall collaborate with the executive |
|
|
commissioner of the Health and Human Services Commission and may |
|
|
convene any necessary workgroups. The members of a workgroup may |
|
|
include: |
|
|
(1) health care providers specializing in asthma and |
|
|
chronic obstructive pulmonary disease prevention, screening, |
|
|
treatment, or research; |
|
|
(2) representatives of general academic teaching |
|
|
institutions as defined by Section 61.003, Education Code, medical |
|
|
and dental units as defined by Section 61.003, Education Code, and |
|
|
medical schools as defined by Section 61.501, Education Code, and |
|
|
other educators with experience with asthma and chronic obstructive |
|
|
pulmonary disease; |
|
|
(3) nonprofit and community organizations serving |
|
|
individuals with asthma and chronic obstructive pulmonary disease; |
|
|
(4) representatives from geographic areas or other |
|
|
population groups at higher risk of asthma and chronic obstructive |
|
|
pulmonary disease; and |
|
|
(5) other people the department determines are |
|
|
necessary. |
|
|
(c) In developing the strategic plan, the Department of |
|
|
State Health Services shall: |
|
|
(1) identify barriers to effective prevention, |
|
|
screening, medication adherence, and treatment for asthma and |
|
|
chronic obstructive pulmonary disease, including specific barriers |
|
|
affecting health care providers and patients; |
|
|
(2) identify methods to increase awareness of the risk |
|
|
factors and symptoms associated with asthma and chronic obstructive |
|
|
pulmonary disease; |
|
|
(3) identify methods to increase the use of |
|
|
evidence-based screening to enhance the number of people screened |
|
|
regularly for asthma and chronic obstructive pulmonary disease; |
|
|
(4) review current technologies and best practices for |
|
|
asthma and chronic obstructive pulmonary disease management and |
|
|
treatment; |
|
|
(5) review technology available to diagnose and |
|
|
prevent asthma and chronic obstructive pulmonary disease; |
|
|
(6) develop methods for creating partnerships with |
|
|
public and private entities to increase awareness of asthma and |
|
|
chronic obstructive pulmonary disease; |
|
|
(7) review current prevention, screening, treatment, |
|
|
and other related activities in this state for asthma and chronic |
|
|
obstructive pulmonary disease and identify areas in which the |
|
|
health care services provided through those activities are lacking; |
|
|
(8) estimate the annual direct and indirect state |
|
|
health care costs attributable to asthma and chronic obstructive |
|
|
pulmonary disease; and |
|
|
(9) make recommendations to the legislature on state |
|
|
policy changes and funding needed to implement the strategic plan. |
|
|
(d) Not later than December 31, 2016, the Department of |
|
|
State Health Services shall deliver to the governor and members of |
|
|
the legislature the strategic plan and recommendations on goal |
|
|
implementation and schedule compliance related to the strategic |
|
|
plan developed as required by this section. |
|
|
(e) This section expires January 1, 2017. |
|
|
SECTION 2. This Act takes effect September 1, 2015. |